
Felzartamab
CAS No. 2197112-39-1
Felzartamab( —— )
Catalog No. M36793 CAS No. 2197112-39-1
Felzartamab(MOR-202) is a human-targeted monoclonal antibody to CD38 for the study of multiple myeloma and advanced antibody-mediated rejection of allogeneic kidney transplants.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 375 | Get Quote |
![]() ![]() |
5MG | 615 | Get Quote |
![]() ![]() |
10MG | 938 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameFelzartamab
-
NoteResearch use only, not for human use.
-
Brief DescriptionFelzartamab(MOR-202) is a human-targeted monoclonal antibody to CD38 for the study of multiple myeloma and advanced antibody-mediated rejection of allogeneic kidney transplants.
-
DescriptionFelzartamab (MOR-202) is a human monoclonal antibody that targets CD38 and can be used in multiple myeloma research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCD38
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2197112-39-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. J. Endell, et al. Effect of MOR202, a human CD38 antibody, in combination with lenalidomide and bortezomib, on bone lysis and tumor load in a physiologic model of myeloma.Meeting Abstract
2011 ASCO Annual Meeting I
2011 ASCO Annual Meeting I
molnova catalog



related products
-
Gabapentin enacarbil
Gabapentin enacarbil is a prodrug for the anticonvulsant and analgesic drug gabapentin.
-
Maresin 2
Maresin 2 (3R,14S-diHDHA) is a specialized pro-ablative lipid mediator (SPM) with anti-inflammatory and analgesic activity, promotes mucosal repair, and reduces neutrophil recruitment in yeast polymerase peritonitis.
-
DB722
DB722 is a furamidine analogues with DNA binding activity. DB722 shows antiproliferative activity.